机译:一种复发多发性骨髓瘤的新风险分层算法的开发与验证
Department of Haemato‐oncologyUniversity Hospital OstravaOstrava Czech Republic;
Department of HaematologyUniversity Hospital LeuvenLeuven Belgium;
Department of Internal Medicine VUniversity Hospital HeidelbergHeidelberg Germany;
Amgen Europe GmbHRotkreuz Switzerland;
Amgen LtdUxbridge UK;
1st Medical Department – Clinical Department of Haematology 1st Faculty of Medicine and General;
4th Department of Medicine ‐ HaematologyCharles University Hospital and Faculty of Medicine Hradec;
Department of Internal Medicine Haematology and OncologyUniversity Hospital Brno and Faculty of;
Amgen Europe GmbHRotkreuz Switzerland;
Pharmerit InternationalRotterdam the Netherlands;
algorithm; multiple myeloma; overall survival; relapsed; risk stratification;
机译:一种复发多发性骨髓瘤的新风险分层算法的开发与验证
机译:在常规临床实践中验证多发性骨髓瘤风险分层指标:来自捷克骨髓瘤组单克隆血友病病登记处的数据分析
机译:验证英国骨髓瘤研究联盟风险概况,新诊断的多发性骨髓瘤患者患者的新临床预测模型,没有资格获得自体干细胞移植; 丹麦国家多骨髓瘤登记处的基于人口的研究
机译:基于深度学习的序列MRI扫描治疗骨髓瘤治疗管理的风险分层
机译:社区生活队列风险分层模型的开发与验证,三种方法比较:逻辑回归,随机森林和Cox比例危险回归
机译:新的风险分层算法估算复发多发性骨髓瘤患者死亡风险:追溯图表审查中的外部验证
机译:复发设定中多发性骨髓瘤患者新风险分层算法的方法